- Home
- CRNC vs EYPT Comparison
CRNC vs EYPT Comparison
Compare CRNC & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNC
- EYPT
- Stock Information
- Founded
- CRNC 2020
- EYPT 1987
- Country
- CRNC United States
- EYPT United States
- Employees
- CRNC N/A
- EYPT N/A
- Industry
- CRNC EDP Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- CRNC Technology
- EYPT Industrials
- Exchange
- CRNC Nasdaq
- EYPT Nasdaq
- Market Cap
- CRNC 445.8M
- EYPT 427.9M
- IPO Year
- CRNC N/A
- EYPT 2005
- Fundamental
- Price
- CRNC $7.59
- EYPT $5.68
- Analyst Decision
- CRNC Buy
- EYPT Strong Buy
- Analyst Count
- CRNC 8
- EYPT 8
- Target Price
- CRNC $8.41
- EYPT $25.71
- AVG Volume (30 Days)
- CRNC 1.1M
- EYPT 907.9K
- Earning Date
- CRNC 05-07-2025
- EYPT 05-07-2025
- Dividend Yield
- CRNC N/A
- EYPT N/A
- EPS Growth
- CRNC N/A
- EYPT N/A
- EPS
- CRNC N/A
- EYPT N/A
- Revenue
- CRNC $244,065,000.00
- EYPT $43,273,000.00
- Revenue This Year
- CRNC N/A
- EYPT N/A
- Revenue Next Year
- CRNC $9.23
- EYPT N/A
- P/E Ratio
- CRNC N/A
- EYPT N/A
- Revenue Growth
- CRNC N/A
- EYPT N/A
- 52 Week Low
- CRNC $2.34
- EYPT $3.91
- 52 Week High
- CRNC $27.50
- EYPT $22.13
- Technical
- Relative Strength Index (RSI)
- CRNC 41.59
- EYPT 50.79
- Support Level
- CRNC $7.08
- EYPT $3.91
- Resistance Level
- CRNC $7.85
- EYPT $5.86
- Average True Range (ATR)
- CRNC 0.74
- EYPT 0.54
- MACD
- CRNC 0.11
- EYPT 0.13
- Stochastic Oscillator
- CRNC 64.33
- EYPT 90.77
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.